Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

Agilent Introduces Breakthrough ICP-MS and MP-AES Platforms

Published: Wednesday, January 08, 2014
Last Updated: Wednesday, January 08, 2014
Bookmark and Share
New systems provide unprecedented performance, value, ease of use.

Agilent Technologies Inc. has introduced the 7900 Inductively Coupled Plasma - Mass Spectrometer (ICP-MS) and the 4200 Microwave Plasma - Atomic Emission Spectrometer (MP-AES), the latest in a series of technologies featured in Agilent's portfolio of spectroscopy solutions.

The 7900 ICP-MS and 4200 MP-AES are the most sophisticated, user-friendly elemental analysis technologies available. Newly streamlined operational features also make them ideal for a wider range of challenging applications and more accessible to a broader spectrum of laboratory personnel.

"At Agilent we continue to introduce 'new to market' technologies across our platforms, enabling our many customers to expand their labs' capabilities and simplify their workflows," said Philip Binns, Agilent vice president of spectroscopy products. "The introduction of the 4200 MP-AES and 7900 ICP-MS further demonstrate our leadership position in elemental analysis and our commitment to providing our customers with the best tools to meet their application needs."

7900 ICP-MS: A New Standard in Quadrupole ICP-MS Performance

"The 7900 ICP-MS redefines the way we analyze samples by extending the application range significantly," said Wim Proper, development analyst, Eurofins Analytico. "With its unprecedented ultra-high matrix capability, the 7900 allows us to easily switch between trace element analysis of demineralized water to high total dissolved solid digests all in the same sequence."

The 7900 ICP-MS is a complete redesign, sharing only a few key components from the world's bestselling 7700 Series. The 7900 has been engineered and optimized to provide elemental laboratories with the industry's most powerful and easy-to-use quadrupole ICP-MS solution. Features include:

Unprecedented matrix tolerance - Ultra-high-matrix introduction technology enables laboratories to measure samples containing up to 25 percent total dissolved solids, 10 times higher than the current benchmark held by the 7700 ICP-MS limit. This enables direct measurement of sample types previously inaccessible by ICP-MS.

Enhanced trace-level detection - A novel interface design, optimized expansion-stage vacuum system and new orthogonal detector system (ODS) reduce background and improve sensitivity, dramatically improving signal to noise for 10-fold lower detection limits than any quadrupole ICP-MS system available.

Widest dynamic range of any quadrupole ICP-MS - Patented ODS technology delivers up to 11 orders of magnitude dynamic range, from sub-ppt to percent-level concentrations, which enables users to measure trace elements and majors in the same run. An industry-first capability, this eliminates analyte-specific tuning and simplifies method development, virtually eliminating over-range results.

Redesigned MassHunter software features a simpler, more intuitive user interface along with powerful method automation capabilities. Another industry first, the new method set-up wizard makes method development easier than ever, automatically building methods based on answers to a simple user questionnaire.

4200 MP-AES Series: A Novel Breakthrough in Entry-Level Elemental Spectroscopy Technology

"The 4200 MP-AES, the latest advancement in Agilent's broadly used microwave plasma-atomic emission spectrometer series, provides the safest, most expansive yet cost-effective elemental analysis capabilities compared with any other entry-level atomic spectroscopy technology," said Agilent's Keith Bratchford, general manager, Atomic Spectroscopy Products.

The 4200 MP-AES features a variety of unique capabilities:

Safe and economical - Because flammable and oxidizing gas sources are not required for use, the system can be left unattended while performing overnight multi-element analysis, which dramatically increases laboratory safety and flexibility and reduces operating costs compared to Flame AA.

Robustness and reliability - Optimized high-performance waveguide and new torch design produces a robust nitrogen plasma, which enables greater tolerance to complex matrix samples such as those used in mining, food and agriculture, chemicals, petrochemicals and manufacturing. Mass flow control of the nebulizer gas enhances accuracy and long term stability in complex samples.

Ease of use - Application-specific software applets plus plug-and-play hardware ensures that with just minimal training, any user can quickly and easily conduct analyses without the need for method development or alignment.

Advanced software platform - Newly released MP Expert software features advanced tools such as "FLIC" and IECs for assisting in eliminating spectral interferences.

Mobile and remote capabilities - With no external cylinder connections and no need for ongoing gas supplies, the MP-AES is ideal for any elemental analysis laboratory-especially remote sites and mobile laboratories. This eliminates the need to plumb multiple gasses into the laboratory or manually transport and handle hazardous gas cylinders.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More Than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Agilent Announces Opening of Life Science Research Center
Facility designed to advance multi-omics research.
Thursday, September 24, 2015
Agilent to Acquire Seahorse Bioscience
Acquisition complements Agilent’s market-leading separations and mass spectrometry solutions, expands pharma offerings.
Thursday, September 10, 2015
Agilent, Singapore Institute Collaborate
Agilent Technologies and Singapore's Bioprocessing Technology Institute today announced a collaboration to develop new analytical approaches to specific protein-linked sugar compounds.
Wednesday, July 15, 2015
Agilent Collaborate with A*STAR’s Bioprocessing Technology Institute
Collaboration addresses a critical need in the biopharmaceutical industry.
Tuesday, July 14, 2015
Agilent Technologies and Waters Corporation Formalize Instrument Control Exchange
Agilent Technologies Inc. and Waters Corp have announced a formal agreement to exchange instrument controls to improve the productivity of customers who own software and instruments from both companies.
Wednesday, July 01, 2015
Agilent Technologies Launches New Products for Analyzing Biotherapeutics
Expanded AdvanceBio portfolio enables scientists to speed research and lower costs.
Thursday, June 25, 2015
Agilent to Focus on "Powerful Partnerships, Inspiring Results" at ASMS 2015
Company to introduce solutions enabling new standards in mass spectrometry, lab productivity.
Friday, May 29, 2015
Agilent Announces New CEO Mike McMullen
McMullen elected as chief executive officer by Company’s board of directors.
Thursday, March 19, 2015
Agilent’s Microarray Scanner Approved for In Vitro Diagnostics in China
Regulators approve SureScan Dx as medical device.
Wednesday, January 28, 2015
Utilizing Fast HPLC Screening Methods for the Detection of Steroids
Analysis of steroids improved by choosing the optimal HPLC column for the separation.
Saturday, January 17, 2015
Agilent Names Alacris Theranostics as Certified Provider of Target Enrichment Services
Customers receive consistent data quality, reproducibility and reliability.
Saturday, January 17, 2015
Benefits of SPE for the Analysis of Mycotoxins
Fast and cost-effective sample preparation is essential for the analysis of mycotoxins in food and feed.
Wednesday, January 14, 2015
Dako, Cell Signalling Tech Partner with Companion Diagnostics
Partnership for development of high-quality, cutting-edge companion diagnostic products for diagnosis and treatment of cancer.
Monday, January 12, 2015
Agilent Technologies - Making Better GC Connections
Improving GC connections for reliable, robust and reproducible results.
Wednesday, December 24, 2014
How to Achieve High-Speed, High-Resolution Glycan Mapping for mAb Characterization
The full characterization of biotherapeutics is required by regulatory authorities as properties such as safety, efficacy and the serum half-life of therapeutic proteins can be affected by differences in their glycosylation pattern.
Monday, December 22, 2014
Scientific News
Genetic Defences of Bacteria Don’t Aid Antibiotic Resistance
Genetic responses to the stresses caused by antibiotics don’t help bacteria to evolve a resistance to the medications, according to a new study by Oxford University researchers.
Detecting HIV Diagnostic Antibodies with DNA Nanomachines
New research may revolutionize the slow, cumbersome and expensive process of detecting the antibodies that can help with the diagnosis of infectious and auto-immune diseases such as rheumatoid arthritis and HIV.
Snapshot Turns T Cell Immunology on its Head
New research may have implications for 1 diabetes sufferers.
Tolerant Immune System Increases Cancer Risk
Researchers have found that individuals with high immunoCRIT ratios may have an increased risk of developing certain cancers.
Developing a Gel that Mimics Human Breast for Cancer Research
Scientists at the Universities of Manchester and Nottingham have been funded to develop a gel that will match many of the biological structures of human breast tissue, to advance cancer research and reduce animal testing.
Cell's Waste Disposal System Regulates Body Clock Proteins
New way to identify interacting proteins could identify potential drug targets.
New Approach to Treating Heparin-induced Blood Disorder
A potential treatment for a serious clotting condition that can strike patients who receive heparin to treat or prevent blood clots may lie within reach by elucidating the structure of the protein complex at its root.
Horse Illness Shares Signs of Human Disease
Horses with a rare nerve condition have similar signs of disease as people with conditions such as Alzheimer’s, a study has found.
How a Molecular Motor Untangles Protein
Diseases such as Alzheimer’s, Parkinson’s and prion diseases, all involve “tangled” proteins.
Compound Doubles Up On Cancer Detection
Researchers have found that tagging a pair of markers found almost exclusively on a common brain cancer yields a cancer signal that is both more obvious and more specific to cancer.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos